(RYAM) Rayonier Advanced Materials - NYSE

Sector: Basic Materials | Industry: Chemicals | Exchange: NYSE (USA) | Market Cap: 548m USD | Total Return: 116.7% in 12m

Cellulose Specialties, Biomaterials, Commodity Pulp, Paperboard
Total Rating 42
Safety 61
Buy Signal -0.03
Chemicals
Industry Rotation: -12.9
Market Cap: 548M
Avg Turnover: 6.52M
Risk 3d forecast
Volatility61.8%
VaR 5th Pctl9.50%
VaR vs Median-8.41%
Reward TTM
Sharpe Ratio1.32
Rel. Str. IBD76.5
Rel. Str. Peer Group84.7
Character TTM
Beta1.304
Beta Downside1.240
Hurst Exponent0.517
Drawdowns 3y
Max DD63.70%
CAGR/Max DD0.43
CAGR/Mean DD1.10
EPS (Earnings per Share) EPS (Earnings per Share) of RYAM over the last years for every Quarter: "2021-06": 1.89, "2021-09": -0.21, "2021-12": -0.37, "2022-03": -0.39, "2022-06": -0.31, "2022-09": 0.28, "2022-12": 0.05, "2023-03": 0.05, "2023-06": -0.25, "2023-09": -0.4, "2023-12": -1.88, "2024-03": -0.02, "2024-06": 0.19, "2024-09": -0.49, "2024-12": -0.1, "2025-03": -0.49, "2025-06": -5.44, "2025-09": -0.07, "2025-12": -0.2686, "2026-03": -1.22,
Last SUE: -0.32
Qual. Beats: 0
Revenue Revenue of RYAM over the last years for every Quarter: 2021-06: 341.019, 2021-09: 374.014, 2021-12: 374, 2022-03: 351.716, 2022-06: 399.22, 2022-09: 466.346, 2022-12: 499.985, 2023-03: 466.761, 2023-06: 385.413, 2023-09: 368.67, 2023-12: 422.486, 2024-03: 387.656, 2024-06: 419.045, 2024-09: 401.103, 2024-12: 422.504, 2025-03: 355.967, 2025-06: 340.048, 2025-09: 352.837, 2025-12: 417, 2026-03: 319.065,
Rev. CAGR: -6.77%
Rev. Trend: -91.0%
Last SUE: 0.43
Qual. Beats: 0

Warnings

High Debt while negative Cash Flow

Interest Coverage Ratio 0.1 is critical

Altman Z'' 0.43 < 1.0 - financial distress zone

Below Avwap Earnings

Tailwinds

No distinct edge detected

Description: RYAM Rayonier Advanced Materials

Rayonier Advanced Materials Inc. (RYAM) is a global manufacturer of cellulose-based products, operating across segments including Cellulose Specialties, Biomaterials, and High-Yield Pulp. The company processes wood fibers into natural polymers used in diverse end-markets such as pharmaceuticals, food thickeners, liquid crystal displays, and automotive components. Its portfolio also extends to commodity-grade viscose for textiles and absorbent fluff pulp for personal hygiene products.

As a specialist in the high-purity cellulose sector, RYAM operates within a capital-intensive industry where market share is often protected by complex chemical processing requirements and high barriers to entry. The company’s biomaterials division reflects a growing industry shift toward circular economy models, converting manufacturing byproducts into biofuels and lignin-based chemicals. For a deeper look into the companys valuation metrics, consider reviewing the latest data on ValueRay.

Headquartered in Jacksonville, Florida, the firm maintains a broad geographic footprint with significant sales exposure to China, Europe, and North America. Its integration into global supply chains ranges from industrial applications like munitions and lacquers to consumer staples such as food packaging and apparel fabrics.

Headlines to Watch Out For
  • Cellulose specialty pricing and volume demand drive primary revenue growth
  • High energy and chemical input costs impact manufacturing profit margins
  • Global textile and construction cycles dictate commodity viscose and pulp demand
  • Biomaterials expansion and biofuel production diversify long-term earnings streams
  • Significant debt leverage and interest rates influence equity valuation and liquidity
Piotroski VR-10 (Strict) 1.5
Net Income: -470.7m TTM > 0 and > 6% of Revenue
FCF/TA: -0.05 > 0.02 and ΔFCF/TA -10.67 > 1.0
NWC/Revenue: 10.08% < 20% (prev 10.49%; Δ -0.41% < -1%)
CFO/TA 0.01 > 3% & CFO 16.3m > Net Income -470.7m
Net Debt (695.5m) to EBITDA (171.7m): 4.05 < 3
Current Ratio: 1.37 > 1.5 & < 3
Outstanding Shares: last quarter (67.1m) vs 12m ago 1.38% < -2%
Gross Margin: 6.10% > 18% (prev 9.56%; Δ -3.47% > 0.5%)
Asset Turnover: 75.51% > 50% (prev 75.49%; Δ 0.01% > 0%)
Interest Coverage Ratio: 0.07 > 6 (EBIT TTM 6.91m / Interest Expense TTM 97.6m)
Altman Z'' 0.43
A: 0.09 (Total Current Assets 529.2m - Total Current Liabilities 385.2m) / Total Assets 1.67b
B: -0.10 (Retained Earnings -171.0m / Total Assets 1.67b)
C: 0.00 (EBIT TTM 6.91m / Avg Total Assets 1.89b)
D: 0.16 (Book Value of Equity 229.4m / Total Liabilities 1.43b)
Altman-Z'' = 0.43 = B
Beneish M -2.83
DSRI: 1.16 (Receivables 173.6m/167.3m, Revenue 1.43b/1.60b)
GMI: 1.57 (GM 9.56% / 6.10%)
AQI: 0.43 (AQ_t 0.10 / AQ_t-1 0.24)
SGI: 0.89 (Revenue 1.43b / 1.60b)
TATA: -0.29 (NI -470.7m - CFO 16.3m) / TA 1.67b)
Beneish M = -2.83 (Cap -4..+1) = A
What is the price of RYAM shares?

As of June 15, 2026, the stock is trading at USD 8.56 with a total of 460,740 shares traded.
Over the past week, the price has changed by +5.68%, over one month by -7.86%, over three months by -25.24% and over the past year by +116.71%.

Is RYAM a buy, sell or hold?

Rayonier Advanced Materials has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy RYAM.

  • StrongBuy: 0
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the RYAM price?
Analysts Target Price 14.5 69.4%
Rayonier Advanced Materials (RYAM) - Fundamental Data Overview as of 12 June 2026
Market Cap USD = 548.3m (548.3m USD * 1.0 USD.USD)
P/E Forward = 27.5482
P/S = 0.3765
P/B = 2.3523
P/EG = 2.6265
Revenue TTM = 1.43b USD
EBIT TTM = 6.91m USD
EBITDA TTM = 171.7m USD
Long Term Debt = 735.5m USD (from longTermDebt, last quarter)
Short Term Debt = 28.0m USD (from shortTermDebt, last quarter)
Debt = 763.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 695.5m USD (calculated: Debt 763.4m - CCE 67.9m)
Enterprise Value = 1.24b USD (548.3m + Debt 763.4m - CCE 67.9m)
Interest Coverage Ratio = 0.07 (Ebit TTM 6.91m / Interest Expense TTM 97.6m)
EV/FCF = -14.78x (Enterprise Value 1.24b / FCF TTM -84.2m)
FCF Yield = -6.77% (FCF TTM -84.2m / Enterprise Value 1.24b)
FCF Margin = -5.89% (FCF TTM -84.2m / Revenue TTM 1.43b)
Net Margin = -32.94% (Net Income TTM -470.7m / Revenue TTM 1.43b)
Gross Margin = 6.10% ((Revenue TTM 1.43b - Cost of Revenue TTM 1.34b) / Revenue TTM)
Gross Margin QoQ = -2.38% (prev 8.87%)
Tobins Q-Ratio = 0.75 (Enterprise Value 1.24b / Total Assets 1.67b)
Interest Expense / Debt = 12.78% (Interest Expense 97.6m / Debt 763.4m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 5.46m (EBIT 6.91m * (1 - 21.00%))
Current Ratio = 1.37 (Total Current Assets 529.2m / Total Current Liabilities 385.2m)
Debt / Equity = 3.33 (Debt 763.4m / totalStockholderEquity, last quarter 229.4m)
Debt / EBITDA = 4.05 (Net Debt 695.5m / EBITDA 171.7m)
 Debt / FCF = -8.26 (negative FCF - burning cash) (Net Debt 695.5m / FCF TTM -84.2m)
 Total Stockholder Equity = 306.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -24.87% (Net Income -470.7m / Total Assets 1.67b)
RoE = -153.5% (Net Income TTM -470.7m / Total Stockholder Equity 306.6m)
RoCE = 0.66% (EBIT 6.91m / Capital Employed (Equity 306.6m + L.T.Debt 735.5m))
RoIC = 0.44% (NOPAT 5.46m / Invested Capital 1.24b)
WACC = 10.29% (E(548.3m)/V(1.31b) * Re(10.57%) + D(763.4m)/V(1.31b) * Rd(12.78%) * (1-Tc(0.21)))
Discount Rate = 10.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 68.89 | Cagr: 1.20%
 [DCF] Fair Price = unknown (Cash Flow -84.2m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.32 | # QB: 0
Revenue Correlation: -91.04 | Revenue CAGR: -6.77% | SUE: 0.43 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.24 | Chg30d=+18.33% | Revisions=+33% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.06 | Chg30d=-42.11% | Revisions=-33% | Analysts=2
EPS current Year (2026-12-31): EPS=-1.10 | Chg30d=-55.63% | Revisions=-33% | GrowthEPS=+82.3% | GrowthRev=+0.1%
EPS next Year (2027-12-31): EPS=1.09 | Chg30d=-7.63% | Revisions=+0% | GrowthEPS=+198.6% | GrowthRev=+8.1%
[Analyst] Revisions Ratio: +33%